Takeda's Largest Study Brings Dengue Vaccine Step Closer

There are approximately five vaccine candidates under evaluation in clinical trials, including other live-attenuated vaccines, as well as subunit, DNA and purified inactivated vaccine candidates. Also, technological approaches, such as virus-vectored and VLP-based vaccines, are under evaluation in preclinical studies. In September 2016, Takeda announced the beginning of the phase 3 clinical trials of its dengue vaccine – TAK-003 vaccine. This vaccine is also aimed at prevention against all four dengue virus strains.

Dengue is a mosquito-borne flavivirus debilitating disease with high prevalence in most tropical and sub-tropical regions. Dengue is a painful disease that is also known as ‘break bone’ fever due to the excruciating bone and joint pain associated with it. No therapeutics have been discovered for treatment of the disease caused by four closely related dengue viruses (DEN-1, DEN-2, DEN-3 and DEN-4). Therefore, focus has been mainly on prevention by controlling the vectors being borne. Severe dengue was discovered in the 1950s during dengue epidemics in Philippines and Thailand. The disease has since spread to Asian and Latin America countries and is one of the leading causes of hospitalization and deaths among children and adults in these regions.

Get PDF for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/23

#Summary: Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Important Features that are under offering & key highlights of the report :

1) What all companies are currently profiled in the report?
Following are list of players that are currently profiled in the the report ”Sanofi Pasteur’s Dengvaxia, Takeda ”

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

2) Can we add or profiled new company as per our need?
Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by research team depending upon the difficulty of survey.
** Data availability will be confirmed by research in case of privately held company. Upto 3 players can be added at no added cost.

3) What all regional segmentation covered? Can specific country of interest be added?
Currently, research report gives special attention and focus on following regions:
North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain etc), South America (Brazil, Argentina etc) & Middle East & Africa (Saudi Arabia, South Africa etc)
** One country of specific interest can be included at no added cost. For inclusion of more regional segment quote may vary.

4) Can inclusion of additional Segmentation / Market breakdown is possible?
Yes, inclusion of additional segmentation / Market breakdown is possible subject to data availability and difficulty of survey. However a detailed requirement needs to be shared with our research before giving final confirmation to client.

** Depending upon the requirement the deliverable time and quote will vary.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/23

To comprehend 2017-2025 Dengue Vaccines Market dynamics in the world mainly, the worldwide 2017-2025 Dengue Vaccines Market is analyzed across major global regions. CMI also provides customized specific regional and country-level reports for the following areas.

• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, and Brazil.
• Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
• Europe: UK, France, Italy, Germany, Spain, and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

2-Page profiles for 10+ leading manufacturers and 10+ leading retailers is included, along with 3 years financial history to illustrate the recent performance of the market. Revised and updated discussion for 2018 of key macro and micro market influences impacting the sector are provided with a thought-provoking qualitative comment on future opportunities and threats. This report combines the best of both statistically relevant quantitative data from the industry, coupled with relevant and insightful qualitative comment and analysis.

Geographical Analysis: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain etc), South America (Brazil, Argentina etc) & Middle East & Africa (Saudi Arabia, South Africa etc)

In order to get a deeper view of Market Size, competitive landscape is provided i.e. Revenue (Million USD) by Players (2013-2018), Revenue Market Share (%) by Players (2013-2018) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Competitive Analysis:

The key players are highly focusing innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies. Company profile section of players includes its basic information like legal name, website, headquarters, its market position, historical background and top 5 closest competitors by Market capitalization / revenue along with contact information. Each player/ manufacturer revenue figures, growth rate and gross profit margin is provided in easy to understand tabular format for past 5 years and a separate section on recent development like mergers, acquisition or any new product/service launch etc.

Get Discount On Full Copy 2017-2025: https://www.coherentmarketinsights.com/insight/request-discount/23

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.